Peter Schneider

Péter Schneider is a seasoned finance professional with extensive experience in the pharmaceutical industry. Currently serving as Chief Financial Officer at Sandoz since January 2024, Péter specializes in cost and sales-result analysis and complex tax modeling. Previous roles include General Manager at HUMVO and Finance Director at Novo Nordisk, where responsibilities included finance business partnership, tax management, and financial oversight for clinical trials and market access activities. Péter's career also includes significant positions at Novartis as CFO and Purchasing Director for Europe East, and at Lapker Group as CFO, with a strong background in corporate finance and procurement. Schneider holds multiple degrees, including a Juris Doctor and Master's degrees in Pharmacoeconomics and Economics, and is pursuing an Executive MBA focused on Pharmaceutical Marketing and Management. Key skills encompass strategy development, Business Intelligence, and SAP implementation.